. Author manuscript; available in PMC: 2016 Jan 1.

Published in final edited form as: Genes Immun. 2015 Apr 30;16(5):362–365. doi: 10.1038/gene.2015.13

Table 1.

Description of the cohort by HIV-1 and BV status

	HIV-1 Infected^b (n =216)			HIV-1 Uninfected (n =156)			Total (n =372)

	BV (n=165)	No BV n=(51)	p-value	BV (n=105)	No BV (n=51)	p-value

Age, years	29 (24, 34)	29 (25, 33)	0.81	27 (22, 31)	28 (24, 33)	0.11	28 (24, 33)
East African	114 (69%)	43 (84%)	0.05	90 (86%)	40 (78%)	0.36	287 (77%)
CD4+ Count (enrollment; cells/mm³)	434 (330, 575)	520 (408, 755)	0.02	-	-		445 (334, 604)
Plasma HIV-1 RNA (enrollment; log₁₀)	4.7 (4.0, 5.1)	4.4 (3.9, 4.9)	0.03	-	-		4.7 (4.0, 5.0)
HSV-2 Infected	164 (99%)	47 (92%)	0.01	99 (94%)	46 (90%)	0.34	353 (95%)

a. Numbers (%) are provided for categorical variables and medians (inter-quartile ranges) are provided for continuous variables.

HIV-1 infected prior to first BV diagnosis